Royal Bank Of Canada Bionano Genomics, Inc. Transaction History

Royal Bank Of Canada

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$0.57 - $1.16 $9,957 - $20,265	-17,470 Reduced 81.18%	4,050 $2,000
Q1 2023 May 15, 2023	SELL	$1.06 - $1.97 $26,480 - $49,214	-24,982 Reduced 53.72%	21,520 $23,000
Q4 2022 Feb 14, 2023	BUY	$1.4 - $25.4 $57,047 - $1.03 Million	40,748 Added 708.17%	46,502 $67,000
Q3 2022 Nov 14, 2022	BUY	$0.36 - $36.0 $705 - $70,560	1,960 Added 51.66%	5,754 $11,000
Q2 2022 Aug 15, 2022	SELL	$12.3 - $27.3 $275,889 - $612,339	-22,430 Reduced 85.53%	3,794 $5,000
Q1 2022 May 16, 2022	SELL	$16.6 - $32.3 $1.78 Million - $3.47 Million	-107,432 Reduced 80.38%	26,224 $67,000
Q4 2021 Feb 14, 2022	BUY	$29.9 - $61.2 $938,620 - $1.92 Million	31,392 Added 30.7%	133,656 $399,000
Q3 2021 Nov 15, 2021	BUY	$51.4 - $68.2 $520,065 - $690,047	10,118 Added 10.98%	102,264 $563,000
Q2 2021 Aug 16, 2021	BUY	$44.1 - $84.0 $4.06 Million - $7.74 Million	92,146 New	92,146 $676,000

4.97K

Ticker BNGO
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 290,140,000
Market Cap $58M
Description
Bionano Genomics, Inc. provides genome analysis software solutions. It offers Saphyr, a sample-to-result solution for structural variation analysis by optical genome mapping for genome analysis and understanding of genetic variation and function; Saphyr instrument, a single-molecule imager; Saphyr Chip, a consumable that packages the nanochannel...

Get notified when there are updates to the investment portfolio of Royal Bank Of Canada, based on Form 13F filings with the SEC.

Stay updated on Royal Bank Of Canada with notifications on news.